On 22 June 2017, Lanxess Deutschland GmbH submitted to the European Chemicals Agency (‘the Agency’) an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 for a Union authorisation of a biocidal product family named ‘LANXESS CMIT/MIT biocidal product family’ of product-types 6, 11, 12 and 13, as described in Annex V to that Regulation, providing written confirmation that the competent authority of the Netherlands had agreed to evaluate the application. The application was recorded under case number BC-HA032066-67 in the Register for Biocidal Products.
Recital 1, Regulation (EU) 2024/2750
In forcesince 25 Oct 2024